Empresa Entasis Therapeutics Holdings Inc.
Acciones
ETTX
US2936141033
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 51
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01/05/15 |
Ruben Tommasi
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/05/15 |
David Altarac
CTO | Chief Tech/Sci/R&D Officer | 63 | 04/11/19 |
Kyle Dow
IRC | Investor Relations Contact | - | - |
Matthew Ronsheim
PRN | Corporate Officer/Principal | 52 | 01/09/20 |
Anna Diaz Triola
PRN | Corporate Officer/Principal | - | 19/07/21 |
John Mueller
PRN | Corporate Officer/Principal | 64 | 01/05/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Hastings
BRD | Director/Board Member | 62 | 01/04/18 |
Director/Board Member | 58 | 01/08/17 | |
Heather Behanna
BRD | Director/Board Member | 49 | 01/08/17 |
David Meek
CHM | Chairman | 59 | 24/06/19 |
Marianne Zhen
BRD | Director/Board Member | 55 | 11/07/22 |
Manoussos Perros
CEO | Chief Executive Officer | 56 | 01/05/15 |
Pavel Raifeld
BRD | Director/Board Member | 40 | 11/07/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 47 851 779 | 44 441 302 ( 92,87 %) | 0 | 92,87 % |
Información de la empresa
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
-3,10 % | 102 mil M | |
+2,11 % | 96,07 mil M | |
-1,80 % | 21,66 mil M | |
-17,75 % | 20,77 mil M | |
-6,91 % | 18,53 mil M | |
-42,00 % | 16,91 mil M | |
-28,19 % | 13,79 mil M | |
+0,18 % | 13,33 mil M | |
+19,90 % | 10,94 mil M |